Loading clinical trials...
Loading clinical trials...
The Effect of Rifampicin on the Plasma Pharmacokinetics of Emtricitabine (FTC) and Tenofovir Alafenamide Fumarate (TAF) and Intracellular Tenofovir-diphosphate (TFV-DP) and FTC-triphosphate (FTC-TP)
Conditions
Interventions
Descovy® (TAF/FTC)
Viread® (TDF)
+1 more
Locations
1
United Kingdom
Chelsea and Westminster Hospital NHS Foundation Trust
London, United Kingdom
Start Date
June 1, 2017
Primary Completion Date
January 10, 2018
Completion Date
January 10, 2018
Last Updated
February 12, 2018
NCT01875588
NCT04929028
NCT07071623
NCT07199335
NCT03087253
NCT05419024
Lead Sponsor
St. Stephens Clinical Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions